OXYGENTA PHARMACEUTICAL LIMITED

Scale -

Ebitda is -15.07 Rs Cr; Annual Decline is -74 %; in Bottom Quartile
PBT is -2.51 Rs Cr; Annual Decline is -92 %; in Bottom Quartile
PAT is -17.57 Rs Cr; Annual Decline is -82 %; Continuous Decline over 3 years; in Bottom Quartile
Quarterly Profit is -2.1 Rs Cr; in Bottom Quartile

Quarterly Ebitda Margin is 1 %; Continuous Growth over 3 Quarters; in Bottom Quartile

PBDIT Margin is -13.33 %; Annual Decline is -68 %; in Bottom Quartile
PAT Margin is -15.55 %; Annual Decline is -76 %; Continuous Decline over 3 years; in Bottom Quartile
Quarterly Profit margin is -6 %; in Bottom Quartile

ROCE is -51.77 %; Annual Decline is -113 %; in Bottom Quartile
ROA is -14.68 %; Annual Decline is -27 %; Continuous Decline over 3 years; in Bottom Quartile
Asset Turnover is 111 %; Annual Decline is -26 %
ROE is 0 %; in Bottom Quartile

Operating cash flow is -27.75 Rs Cr; Annual Decline is -1167 %; in Bottom Quartile

Long term Debt is 75.29 Rs Cr; Annual Growth is 250 %; in Top Quartile
Total Debt is 110 Rs Cr; Annual Growth is 76 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 20 %

Operating cashflow/ebitda is 184 %; Annual Growth is 715 %; in Top Quartile
Operating cashflow/PAT is 158 %; Annual Growth is 688 %; in Top Quartile
Exceptional Items/PBT is 0 %; Annual Decline is -98 %; in Top Quartile
Change in Inventories/Total Expenses is -6 %; Annual Decline is -96 %; Continuous Decline over 3 years; in Bottom Quartile
Other Expenses/Total Expenses is 0 %; Annual Decline is -99 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -68 %

Sector

Major Subsidiaries/Associates

Key Clients

Products

Product details

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: